Orthopedics giant Biomet will provide European distribution for Titan Spine's Endoskeleton interbody fusion devices.
Biomet signed a European distribution deal for Titan Spine's Endoskeleton interbody fusion devices, beginning in Germany and spreading through the E.U., the companies announced.
Biomet says it's closed the buyout of Lanx Inc. ahead of its Nov. 29 deadline.
Biomet said today that it closed the acquisition of spinal device maker Lanx Inc.
When the deal was announced early last month, Biomet said it would expand its spine offering with Lanx's Timberline and Aspen spinal fusion systems. The deal was originally expected to close by Nov. 29.
Medical devices are not the cause of varying prices across the healthcare spectrum, according to a study released by the Advance Medical Technology Assn. today, but instead have helped keep healthcare costs down.
Medical devices are not the cause of price variations in hospital care across the U.S., but rather are a part of the solution, according to medical device industry lobbying group AdvaMed.
"It is really clear in the evidence provided by these and other studies that medical devices are not the problem when it comes to rising healthcare costs. In fact, they’re a big part of the solution," Biomet CEO & AdvaMed board member Jeff Binder said during a conference call today.
The 1st patient in an investigational device exemption trial is implanted with Biomet's stemless shoulder replacement device.
Biomet said it's completed the first U.S. implantation in an investigational device exemption trial of its Comprehensive Nano stemless shoulder device.
The stemless shoulder, which is already on the market in Europe, is based on Biomet's T.E.S.S. stemless shoulder, which has been on the market since 2004.
Biomet swings to fiscal 1st-quarter black and announces the acquisition of spinal implant maker Lanx Inc. for an undisclosed amount.
Biomet said it's agreed to acquire spinal implant maker Lanx Inc. for an undisclosed amount as it revealed a swing to fiscal 1st-quarter black.
The Warsaw, Ind.-based orthopedics giant said the deal will expand its spine offering with Lanx's Timberline and Aspen spinal fusion systems.
Stryker Corp. sues orthopedics rival Biomet and a pair of ex-sales reps, accusing them of a scheme to poach Stryker sales teams and diverting customers.
Annual losses at Biomet increase dramatically in a revised earnings release for the Warsaw, Ind.-based orthopedics maker.
Biomet amended its Q4 and annual earnings report to reflect a swing to red in Q4 and much deeper losses for the full year compared to earlier reports.
The Warsaw, Ind.-based orthopedics company posted losses of $221.2 million on $784 million in sales during the 3-month period ended May 31, 2013. An initial earnings report released in July had reported a $20.5 million profit for the quarter.